Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00250445
Status:
COMPLETED
Last Update Posted:
2022-02-18
First Post:
2005-11-07
Brief Title:
A Study to Evaluate the Safety of an Investigational Drug Etoricoxib in Patients With Osteoarthritis OA or Rheumatoid Arthritis RA0663-066
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A Randomized Double-Blind Active-Comparator-Controlled Parallel-Group Study to Evaluate the Safety of Etoricoxib in Patients With Osteoarthritis or Rheumatoid Arthritis
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is designed to compare the risk of cardiovascular events heart attacks strokes in patients receiving either etoricoxib or diclofenac It will also compare the gastrointestinal tolerability of the two medicines The study will be conducted in patients with either rheumatoid or osteo-arthritis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005_100 | None | None | None |